Depression a key factor in health of Parkinson's patients: study

November 28, 2012
Depression a key factor in health of parkinson's patients: study
Researchers add that it is difficult to diagnose because movement disorder masks symptoms.

(HealthDay)—Depression is the most important determinant of the health status of people with Parkinson's disease, according to early findings from a large study of Parkinson's patients.

Parkinson's is a that affects muscle and causes tremors, muscle rigidity and slowed movement. It's believed that about half of Parkinson's patients experience some form of depression at some point, and research suggests that depression and anxiety are more common in Parkinson's patients than in patients with other .

The early findings from the Parkinson's Outcomes Project were released Wednesday by the National Parkinson Foundation and suggest that the impact of depression on the of Parkinson's patients is almost twice that of the movement problems associated with the disease.

The researchers also noted that depression can be difficult to diagnose in Parkinson's patients because many common disease symptoms, such as fatigue and masked , may hide . Studies show that it is common for depression to be undiagnosed or under-treated in Parkinson's patients.

Based on these new findings, the National Parkinson Foundation recommends that doctors screen Parkinson's patients for depression at least once a year, and that patients discuss any mood changes with a health care professional.

When going to doctors' appointments, a patient should be accompanied by a family member who can provide information about any mood changes they've noticed in the patient.

The Parkinson's Outcomes Project began in 2009 and includes more than 5,500 Parkinson's patients in the United States and three other countries.

"Routine aspects of care are rarely studied, so this research is invaluable in proving that there are vast disparities in Parkinson's treatment and showing which aspects of care really work," Dr. Matthew Stern, of the University of Pennsylvania, who is also president-elect of the Movement Disorder Society, said in the news release.

"For example, this latest data demonstrates how important it is to quality care to refer patients for multi-faceted treatment of depression," he added.

Explore further: New explanation for cognitive problems of Parkinson's patients

More information: We Move has more about Parkinson's disease.

Related Stories

New explanation for cognitive problems of Parkinson's patients

November 28, 2012
The hallmark of Parkinson's Disease is the uncertain gait and movement caused by the destructions of neurons producing the neurotransmitter dopamine.

Canada: Parkinson's guidelines set standard for care

July 24, 2012
(Medical Xpress) -- It’s been five years in the making but health-care workers across the country now have guidelines on how to diagnose and treat patients with Parkinson’s disease.

People with Parkinson's disease may have double the risk for melanoma

June 6, 2011
An analysis of several studies shows that people with Parkinson's disease have a significantly higher risk of melanoma, the most dangerous type of skin cancer and the leading cause of death from skin diseases. The research ...

Drugs ease depression in Parkinson's patients without worsening other symptoms

April 11, 2012
Today's anti-depressant medications can ease depression in Parkinson's patients without worsening other symptoms of the disease, according to a study published online in Neurology, the medical journal of the American Academy ...

Recommended for you

Bicycling 'overloads' movement networks with Parkinson's

September 23, 2017
(HealthDay)—Bicycling suppresses abnormal beta synchrony in the Parkinsonian basal ganglia, according to a study published online Sept. 11 in the Annals of Neurology.

Researchers find new path to promising Parkinson's treatment

September 19, 2017
Three researchers at The University of Alabama are part of work that is leading to a new direction for drug discovery in the quest to treat Parkinson's disease.

Tug of war between Parkinson's protein and growth factor

September 18, 2017
Alpha-synuclein, a sticky and sometimes toxic protein involved in Parkinson's disease (PD), blocks signals from an important brain growth factor, Emory researchers have discovered.

Medical history can point to earlier Parkinson's disease diagnosis

September 15, 2017
Before symptoms become pronounced, there is no reliable way to identify who is on track to develop Parkinson's disease, a debilitating movement disorder characterized by tremors, slowness of movement, stiffness, and difficulty ...

Brain rewiring in Parkinson's disease may contribute to abnormal movement

September 14, 2017
The brain's own mechanisms for dealing with the loss of dopamine neurons in Parkinson's disease may be a source of the disorder's abnormal movement, according to a Northwestern Medicine study published in Neuron.

Treating with antioxidants early in Parkinson's disease process may halt degeneration and improve neuronal function

September 7, 2017
Northwestern Medicine scientists have identified a toxic cascade that leads to neuronal degeneration in patients with Parkinson's disease (PD) and figured out how to interrupt it, reports a study to be published September ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.